These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. Farkouh ME, Dangas G, Leon MB, Smith C, Nesto R, Buse JB, Cohen DJ, Mahoney E, Sleeper L, King S, Domanski M, McKinlay S, Fuster V. Am Heart J; 2008 Feb 25; 155(2):215-23. PubMed ID: 18215589 [Abstract] [Full Text] [Related]
8. Revascularization in high risk patients: diabetes mellitus. Cola C, Sabaté M. Minerva Cardioangiol; 2007 Oct 25; 55(5):557-77. PubMed ID: 17912163 [Abstract] [Full Text] [Related]
12. Revascularisation strategy for diabetic multivessel coronary arteriopathy. Raghuram AR. J Indian Med Assoc; 2006 Apr 25; 104(4):186, 188-9, 194. PubMed ID: 16910325 [Abstract] [Full Text] [Related]
13. Diabetes and percutaneous coronary revascularization in the drug-eluting stent era. Safley DM, Marso SP. Herz; 2004 Aug 25; 29(5):542-50. PubMed ID: 15340741 [Abstract] [Full Text] [Related]
14. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Rodés-Cabau J, Deblois J, Bertrand OF, Mohammadi S, Courtis J, Larose E, Dagenais F, Déry JP, Mathieu P, Rousseau M, Barbeau G, Baillot R, Gleeton O, Perron J, Nguyen CM, Roy L, Doyle D, De Larochellière R, Bogaty P, Voisine P. Circulation; 2008 Dec 02; 118(23):2374-81. PubMed ID: 19029471 [Abstract] [Full Text] [Related]
15. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry. Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE. Catheter Cardiovasc Interv; 2009 Jun 01; 73(7):874-80. PubMed ID: 19180665 [Abstract] [Full Text] [Related]
16. Revascularization strategies for stable multivessel and unprotected left main coronary artery disease: from BARI to SYNTAX. Hahalis G, Dangas G, Davlouros P, Alexopoulos D. Int J Cardiol; 2011 Dec 01; 153(2):126-34. PubMed ID: 21474193 [Abstract] [Full Text] [Related]
17. Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database. McGuire DK, Anstrom KJ, Peterson ED. Circulation; 2003 Apr 15; 107(14):1864-70. PubMed ID: 12668513 [Abstract] [Full Text] [Related]
18. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW. Circulation; 2008 Sep 09; 118(11):1146-54. PubMed ID: 18725490 [Abstract] [Full Text] [Related]
19. Diabetic endovascular disease: role of coronary artery revascularization. Stone KE, Chiquette E, Chilton RJ. Am J Cardiol; 2007 Feb 19; 99(4A):105B-112B. PubMed ID: 17307063 [Abstract] [Full Text] [Related]
20. Surgical versus percutaneous revascularization of coronary artery disease in diabetic patients. Cook S, Windecker S. Best Pract Res Clin Endocrinol Metab; 2009 Jun 19; 23(3):317-34. PubMed ID: 19520306 [Abstract] [Full Text] [Related] Page: [Next] [New Search]